Sugi Predict

Sugi Predict / Compounds / SCHEMBL283868

SCHEMBL283868

SCHEMBL283868

Cc1ccc(S(=O)(=O)OCC2CCC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.46
▸ CYP2D6 P10635 4/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ CYP3A4 P08684 4/20 0.42
▸ TSHR P16473 3/20 0.42
▸ POLB P06746 2/20 0.41
▸ ENPP3 O14638 2/20 0.41
▸ ENPP1 P22413 2/20 0.41
▸ ENPP2 Q13822 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ STAT3 P40763 1/20 0.40
▸ MCOLN3 Q8TDD5 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CD4 P01730 1/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL79261 0.97 ALDH1A1 (0.46) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL1553777 0.95 ALDH1A1 (0.49) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL5561307 0.95 ALDH1A1 (0.49) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL956080 0.95 ALDH1A1 (0.49) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL7032005 0.93 CYP2D6 (0.45) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL7166740 0.93 CYP2D6 (0.45) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL26655167 0.93 CYP2D6 (0.45) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL26655196 0.93 CYP2D6 (0.45) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL6591412 0.88 ACHE (0.43) ACHECYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL6591405 0.88 ACHE (0.43) ACHECYP2D6CYP1A2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239752-A1 BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-07-18 — — US disclosed
US-20240239752-A1 BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-07-18 — — US disclosed
US-20240239752-A1 BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-07-18 — — US disclosed
CN-117986264-A Benzo nitrogen-containing polycyclic derivative regulator and preparation method and application thereof 江苏豪森药业集团有限公司 2024-05-07 — — CN disclosed
CN-117486888-A Tricyclic compounds and uses thereof 和记黄埔医药（上海）有限公司 2024-02-02 — — CN disclosed
CN-117486890-A Tricyclic compounds and uses thereof 和记黄埔医药（上海）有限公司 2024-02-02 — — CN disclosed
CN-117120419-A KLK5 bicyclic heteroaromatic inhibitors 拜奥克里斯特制药公司 2023-11-24 — — CN disclosed
CN-113966336-B Tricyclic compounds and uses thereof 和记黄埔医药（上海）有限公司 2023-11-07 — — CN disclosed
US-20230257380-A1 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE CULLGEN (SHANGHAI), INC. (CN) 2023-08-17 — — US disclosed
CN-113966336-A Tricyclic compound and use thereof 和记黄埔医药（上海）有限公司 2022-01-21 — — CN disclosed
EP-0835246-B1 AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ASTRAZENECA AB (SE) 2001-10-24 — — EP disclosed
US-20010031745-A1 Antiviral purine derivatives UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2001-10-18 — — US disclosed
CN-1313854-A Antiviral pyrimidinedione derivatives and process for the preparation thereof SAMJIN PHARM CO LTD (KR) 2001-09-19 — — CN disclosed
EP-1100786-A1 ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Samjin Pharmaceutical Co., Ltd. (KR) 2001-05-23 — — EP disclosed
WO-2000061563-A1 ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2000-10-19 — — WO disclosed
WO-2000061564-A1 ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2000-10-19 — — WO disclosed
US-5994353-A ANTIARTHRITIC AGENTS; ANALGESICS; ANTIINFLAMMATORY AGENTS ZENECA LIMITED (GB) 1999-11-30 — — US disclosed
EP-0835246-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZENECA LIMITED (GB) 1998-04-15 — — EP disclosed
WO-1997000863-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZENECA LIMITED (GB) 1997-01-09 — — WO disclosed
US-4220795-A MODIFIERS OF SMOOTH MUSCLE ACTIVITY, PLATELET ANTIAGGREGATING AGENTS, GASTRIC ANTISCRETORY AGENTS, BRONCHODILATORS MILES LABORATORIES, INC. (US) 1980-09-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257380-A1 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE MUSK, ERBB2, NTRK1 ACHE 3607/4885CYP2D6 4098/4885CYP1A2 4437/4885
US-20240239752-A1 BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 KLK5, KLK1, KLKB1 ACHE 1821/4885CYP2D6 1233/4885CYP1A2 1053/4885
US-20010031745-A1 Antiviral purine derivatives PNP, TYMP, MTAP ACHE 2799/4885CYP2D6 1659/4885CYP1A2 3072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.